Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leukocytapheresis for ulcerative colitis].

K Fukunaga1, K Sawada, S Chikano

  • 1Department of Internal Medicine IV, Hyogo College of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 26, 1999
PubMed
Summary

Leukocytapheresis (LCAP) offers a novel, effective treatment for ulcerative colitis (UC). This extracorporeal circulation therapy shows significant symptom improvement and a favorable safety profile compared to traditional treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2013
Same author

Esophageal replacement by colon interposition with microvascular surgery for patients with thoracic esophageal cancer: the utility of superdrainage.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2012
Same author

Acute lung injury following an esophagectomy for esophageal cancer, with special reference to the clinical factors and cytokine levels of peripheral blood and pleural drainage fluid.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2008
Same author

A variant form of hMTH1, a human homologue of the E coli mutT gene, correlates with somatic mutation in the p53 tumour suppressor gene in gastric cancer patients.

Journal of medical genetics·2004
Same author

Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

[MTH1 functions in the prevention of the spontaneous mutations].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·2001

Area of Science:

  • Gastroenterology
  • Immunology
  • Biomedical Engineering

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease requiring effective treatment options.
  • Extracorporeal circulation therapy (ECCT), including Leukocytapheresis (LCAP) and Granulocytapheresis (GCAP), presents a novel therapeutic approach.
  • Conventional treatments for UC can have limitations and side effects.

Observation:

  • A 7-week intensive therapy regimen involving weekly LCAP and prednisolone (PSL) was administered to UC patients.
  • Patients receiving LCAP showed significant improvements in both subjective and objective UC symptoms.
  • A comparative analysis was conducted against patients treated with intravenous PSL administration.

Findings:

  • LCAP treatment resulted in statistically significant symptom amelioration in UC patients.

Related Experiment Videos

  • LCAP demonstrated a superior safety profile compared to other pharmacological treatments for UC.
  • Previous studies indicate a low incidence of mild and temporary side effects (9.9% in 1,978 sessions).
  • Implications:

    • LCAP emerges as a potentially first-line therapy for UC patients refractory to or with severe complications from standard drug treatments.
    • The findings support LCAP as a safe and effective alternative in managing ulcerative colitis.
    • Further research into ECCT modalities like LCAP can advance inflammatory bowel disease management strategies.